Experience

Pharmaron

• China
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Sr. Director, Business Development

  • Oct 2022 - Present



Jixing Pharmaceuticals

• China
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Executive Director, Business Development and Alliance Management

  • Feb 2022 - Oct 2022



WuXi AppTec

• China
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Director for Business Development

  • Jul 2018 - Feb 2022

  Business development for Laboratory Testing Division (LTD)The LTD platform covers a broad spectrum of drug development areas from discovery, IND to NDA. The services include: DMPK, Analytical Testing, Bioanalytical Testing and Preclinical Safety/Toxicology. The WuXi IND (WIND) platform is a fully integrated IND package including CMC, Non-clinical Testing, Dossier Preparation, Project Management and Regulatory Support (Global). It is a one-stop shop to help expedite your drug development process. Show less

• Key Account Manager, Pacific Northwest Territory

  • Jan 2016 - Jun 2018

  Representing WuXi Apptec, Laboratory Testing Division. WuXi offers integrated drug development services to global clients. Comprehensive service offerings include: Analytical testing (R&D & CMC), DMPK, Biology (in vitro & in vivo), Oncology (CRISPR, in vitro assays & in vivo modeling), Immunology (FACS, Histology, in vivo models),Toxicology, and Bioanalytical (Large & Small molecule).



Champions Oncology, Inc.

• United States
• Biotechnology
• 100 - 200 Employee

• Director, Business Development, TOS

  • Jun 2014 - Dec 2015

  Responsible for all Translational Oncology Research services in the Pacific Northwest territory Responsible for all Translational Oncology Research services in the Pacific Northwest territory



Epitomics

• Burlingame, CA, USA

• Business Development Manager

  • Feb 2011 - May 2014

  Business Development Manager, Epitomics, an Abcam Company, Burlingame, CA, February 2011 – Present (3 years) Business Development and Project Management in Custom Antibody Service • Developing and executing sales strategies and expand business within assigned territory; • Developing and maintaining effective customer relations within assigned territory; • Negotiating contracts, commercial agreements and licensing terms; • Acting as a primary liaison between Epitomics and customers to ensure the successful delivery of custom projects; • Providing training to new team members and supervised one team member; • Researching competitor and industry trend and participating in the development of new products/services; • Supporting regional sales representatives and customer service staff by providing technical information, product recommendations for customer applications, etc.; • Managing pricing within territory to control profitability; • Maintaining accurate reporting, records, and files necessary for strategic planning, market analyses, sales budgeting and forecasting; • Attending trade shows and positively representing Abcam at all times. Show less



University of California, San Francisco

• United States
• Higher Education
• 700 & Above Employee

• Postdoctoral Scholar

  • Jun 2004 - Feb 2011

  Mentor: Dr. Rik Derynck Investigated the nutrient signaling pathways in the regulation of protein translation and cell size. • Discovered the essential role of TGF-β signaling in high glucose-induced cell growth • Discovered novel mechanisms of high glucose-regulated activation of TGF-β signaling HONORS AND FELLOWSHIPS NIH Institutional Research Service Award, 2009-2011 Postdoctoral Travel Award-University of California, San Francisco, 2009 PUBLICATIONS Wu L., Derynck R. (2009) Essential role of TGF-beta in glucose-induced cell hypertrophy. Developmental Cell 17(1): 35-48. (This article is accompanied by a Preview on Developmental Cell 17(1): 6-8) Ren YS*, Wu L.*, Frost AR., Grizzle W., Wan M (2009) Dual Effects of TGF-beta on ERalpha-mediated Estrogenic Transcriptional Activity in Breast Cancer. Molecular Cancer 2009, 8:111. (*: These authors contributed equally) Wu L., Wu X. (2007) Current application of nanotechnology in cancer prevention and treatment. Chinese Cancer Prevention and Treatment 14(22): 1740-1743. Xu J., Keeton A.B., Wu L., Franklin J.L., Cao X., Messina J. L. (2005) Gene 33 inhibits apoptosis of breast cancer cells and increases poly(ADP-ribose) polymerase expression. Breast Cancer Research and Treatment 91(3):207-15. Li Q., Wu L., Oelschlager DK, Wan M, Stockard CR, Grizzle WE, Wang N, Chen H, Sun Y, Cao X (2005) Smad4 inhibits tumor growth by inducing apoptosis in estrogen receptor alpha positive breast cancer cells. Journal of Biological Chemistry 280: 27022-27028. Wu L.,Wu Y., Gathings B., Wan M., Li X., Grizzle W., Liu Z., Lu C., Mao Z., Cao X.(2003) Smad4 as a Transcription Corepressor for Estrogen Receptor α. Journal of Biological Chemistry 278: 15192-15200. Wan M., Cao X.S., Wu Y., Bai S., Wu L., Shi X.M., Li L., Cao X. (2002) Jab-1 Antagonizes TGF-β Signaling by Inducing Smad4 Degradation. EMBO Reports 3: 171-176. Show less